From Inflammation to Targeted Therapy: Leveraging Neutrophil, Platelet, RBC, and Macrophage Biology for Nanocarrier in Atherosclerosis.
Saved in:
| Title: | From Inflammation to Targeted Therapy: Leveraging Neutrophil, Platelet, RBC, and Macrophage Biology for Nanocarrier in Atherosclerosis. |
|---|---|
| Authors: | Heydari F; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization Building, Next to the Milad Tower, Hemmat Exp. Way, Tehran, P.O.Box:14665-1157, Iran.; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran., I. R. of Iran., Hamblin MR; Laser Research Centre, University of Johannesburg, Doornfontein, 2028, South Africa. hamblin.lab@gmail.com., Naghinezhad J; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization Building, Next to the Milad Tower, Hemmat Exp. Way, Tehran, P.O.Box:14665-1157, Iran. jalalalinaghinezhad@gmail.com.; Department of Laboratory Hematology, Mashhad University of Medical Sciences, Faculty of Medicine, Mashhad, Iran., I.R. of Iran. jalalalinaghinezhad@gmail.com.; Department of Medical Laboratory Sciences, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran., I. R. of Iran. jalalalinaghinezhad@gmail.com. |
| Source: | Current atherosclerosis reports [Curr Atheroscler Rep] 2026 Feb 24; Vol. 28 (1). Date of Electronic Publication: 2026 Feb 24. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6242 (Electronic) Linking ISSN: 15233804 NLM ISO Abbreviation: Curr Atheroscler Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
